© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
October 01, 2017
From the Chairman
UNTIL ONCOLOGISTS ARE ABLE to cure every case of bladder cancer, treatment won’t rise to the level we envision. But the development of therapies for people with the disease is moving in the right direction — and remarkably swiftly.
September 22, 2017
Cancergraph, a smartphone app, helps patients track their symptoms and report them to doctors.
September 20, 2017
A clinical trial will test whether partial prostate ablation matches radical prostatectomy in effectiveness — with fewer early side effects.
After a drop, the frequency of PSA screening for prostate cancer has stabilized.
September 19, 2017
A targeted drug for women with ovarian cancer may also benefit men with prostate cancer who have similar genetic mutations. A phase 3 trial is designed to find out.
Study: To prolong survival in early-stage prostate cancer that is low-risk, observe instead of operating.
September 15, 2017
The latest drugs for advanced kidney cancer are stirring optimism.
Scientists are looking for more and better ways to identify the prostate cancers that are most likely to become aggressive.
September 14, 2017
Immunotherapies known as checkpoint inhibitors are so promising in bladder cancer that many patients want them as first treatments — before they’ve been proven in that setting.
My Nemesis the Gold-Capped Vial
Patients with Hematologic Cancers Benefit from a Walking Program
Jakafi-Novel Therapy Combo Improves Symptom Burden in Patients with Myelofibrosis
Doctor’s Experience as a Cancer Caregiver Is Helping Educate Others